Oyo’s founder and CEO, Ritesh Agarwal, is set to increase his ownership in the company by purchasing shares worth Rs 550 crore, according to documents seen by ...

Mankind Pharma's plan to acquire Bharat Serums and Vaccines for ₹13,630 crore has been approved by the Competition Commission of India (CCI). The approval was ...

Stock Market Update:Mankind Pharma's share price surged by 4.6% to ₹2240.00 on the BSE this Friday, following the announcement of its plan to buy a 100% ...

Mankind Pharma announced on Tuesday that it has partnered with Japanese drug maker Takeda to market the acidity drug Vonoprazan in India. This agreement lets ...

After a strong performance in June 2024, the Nifty index rose by 6.6%, thanks to the return of the NDA government and strong economic indicators like 8.2% GDP ...

Jindal Stainless: The company reported a 30% YoY fall in consolidated net profit to ₹501 crore in the March quarter due to compromised margins amid falling ...

On Monday's trading session, the share price of Mankind Pharma surged by 4.79%, reaching ₹2,012, propelled by the pharmaceutical company's inclusion in the ...